A (NIH)-sponsored clinical trial of a candidate vaccine to prevent Lassa fever has begun enrolling participants at the University of Maryland School of Medicine, Baltimore.

Shares of Genuine Parts Co. GPC rallied 1.21% to $123.48 Monday, on what proved to be an all-around positive trading session ...